Clinical Relevance of Failure to Achieve Early Molecular Response in Chronic Myeloid Leukemia in Chronic Phase

被引：0
|
作者：
Lee, Ji Yun [1 ]
Lim, Sung Hee [1 ]
Kim, Hae Su [1 ]
Yoo, Kwai Han [1 ]
Song, Haa-Na [1 ]
Cho, Jinhyun [1 ]
Park, Silvia [1 ]
Kim, Seok Jin [1 ]
Kim, Won Seog [1 ]
Kim, Kihyun [1 ]
Jang, Jun Ho [1 ]
Jung, Chul Won [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia
    Wang, Rui
    Cong, Yue
    Li, Caili
    Zhang, Chen
    Lin, Hai
    MEDICINE, 2019, 98 (15)
  • [2] Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?
    Branford, Susan
    HAEMATOLOGICA, 2020, 105 (12) : 2730 - 2737
  • [3] Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3-and 6-month time points
    Lapusan, Simona
    Yong, Agnes
    Savani, Bipin N.
    Mohty, Mohamad
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (02) : 103 - 112
  • [4] Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
    Rosti, G
    Martinelli, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    De Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Soverini, S
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    BLOOD, 2004, 103 (06) : 2284 - 2290
  • [5] Assessment of Early Molecular Response in Tunisian Chronic Myeloid Leukemia
    Frikha, Rim
    Elloumi, Moez
    Kamoun, Hassen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S230 - S230
  • [6] Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia
    Chikkodi, Santosh V.
    Malhotra, Pankaj
    Naseem, Shano
    Khadwal, Alka
    Prakash, Gaurav
    Sahu, Kamal Kant
    Kumari, Savita
    Suri, Vikas
    Varma, Neelam
    Varma, Subhash
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S114 - S119
  • [7] Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    CANCER, 2011, 117 (23) : 5261 - 5270
  • [8] MEAN CORPUSCULAR VOLUME CAN BE AN EARLY PREDICTOR FOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS
    Ozkan, M. Comert
    Kaya, E.
    Cirik, S.
    Kuku, I.
    Erkurt, M.
    LEUKEMIA RESEARCH, 2017, 61 : S28 - S28
  • [9] Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays
    Bennour, Ayda
    Saad, Ali
    Sennana, Halima
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 97 : 263 - 274
  • [10] HIGH DOSE IMATINIB TO ACHIEVE MOLECULAR RESPONSES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN LATE CHRONIC PHASE AND COMPLETE CYTOGENETIC RESPONSE: IS IT WORTHWHILE?
    Stagno, F.
    Vigneri, P.
    Massimino, M.
    Del Fabro, V.
    Stella, S.
    Berretta, S.
    Messina, A.
    Di Raimondo, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 433 - 433
12345